argus

SENORES PHARMACEUTICALS LIMITED

NSE: SENORESINE0RB801010₹6,682 Cr

Timeline

Time (IST)TypeMEventSrc
05 Nov, 06:44 pm—…Senores Pharmaceuticals Limited has informed the Exchange about Intimation under regulation 30 of Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015nse
05 Nov, 06:41 pm—…Senores Pharmaceuticals Limited has informed the Exchange regarding updates on USFDA Inspection at Havix Group Inc. d/b/a Aavis Pharmaceuticals, material subsidiary of the Companynse
29 Oct, 06:20 pm—…Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q2FY26 scheduled to be held on November 06, 2025 at 05:00 P.M. (IST)nse
29 Oct, 06:12 pm—…Senores Pharmaceuticals Ltd - 544319 - Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025 And To Transact Other Business Mattersbse
08 Oct, 07:17 pm—…Senores Pharmaceuticals Limited has informed the Exchange regarding change in email address of MUFG Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Companynse
18 Sept, 03:58 pm—…Senores Pharmaceuticals Limited has informed the Exchange regarding investment through Right Issue in Senores Pharmaceuticals Inc., Wholly Owned Subsidiary of the Company.nse
18 Sept, 03:55 pm—…Senores Pharmaceuticals Ltd - 544319 - Intimation Under Regulation 30(6) Of SEBI (LODR) Regulations, 2015.bse
12 Sept, 05:39 pm—…Senores Pharmaceuticals Limited has informed the Exchange regarding updates in respect of earlier intimations dated March 11, 2025, March 12, 2025 , April 22, 2025 and June 23, 2025nse
12 Sept, 05:36 pm—…Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
05 Sept, 04:07 pm—…Senores Pharmaceuticals Ltd - 544319 - Reg. 34 (1) Annual Report.bse
02 Sept, 03:00 pm—…Senores Pharmaceuticals Limited has informed the Exchange about Re-Scheduling of Investor Meetnse
02 Sept, 02:50 pm—…Senores Pharmaceuticals Ltd - 544319 - Re-Scheduling Of The Analyst / Institutional Investor Meetings Under The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations 2015bse
01 Sept, 06:34 pm—…Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
01 Sept, 05:26 pm—…Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse